retatrutide clinical trials phase 2 Trial retatrutide clinical trials status 2025

Some of the most commonly discussed include: Wegovy, Zepbound, and Saxenda are approved for weight loss

This growing pipeline means that in the coming years, more oral GLP-1 options could become available, giving patients easier, needle-free ways to manage diabetes and weight

Is cardiometabolic risk improved by weight-loss drugs

(8) Excess body weight increases the mechanical load on weight-bearing joints, accelerating cartilage wear and joint degeneration, and contributing to a pro-inflammatory state that further exacerbates joint damage

Bariatric surgery leads to short-term effects on sweet taste sensitivity and hedonic evaluation of fatty food stimuli

Avoid large drinks with meals